Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve.
about
Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVFInterventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)The Gynecologist Has a Unique Role in Providing Oncofertility Care to Young Cancer PatientsDifferent ovarian stimulation protocols for women with diminished ovarian reserveThe meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian responseCost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers.Antral follicle count in normal (fertility-proven) and infertile Indian women.Age-associated changes in bovine oocytes and granulosa cell complexes collected from early antral follicles.Antral follice counts (AFC) predict ovarian response and pregnancy outcomes in oocyte donation cyclesAssociation between self-reported questionnaire data on fertility and results of hormone analyses in women after childhood cancer: a cross-sectional study.Demographic characteristics and clinical profile of poor responders in IVF / ICSI: A comparative study.Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?A systematic review of tests predicting ovarian reserve and IVF outcome.Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view.Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.Ovarian hyperstimulation syndrome, the master of disguise?The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile womenPredicting pregnancy in women undergoing in-vitro fertilization with basal serum follicle stimulating hormone levels between 10.0 and 11.9 IU/LIndividualized recombinant human follicle-stimulating hormone dosing using the CONSORT calculator in assisted reproductive technology: a large, multicenter, observational study of routine clinical practice.The value of human chorionic gonadotropin stimulation test in predicting ovarian response during in-vitro fertilization.Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization.Ovarian reserve testsSerum anti-Müllerian hormone levels as a predictor of the ovarian response and IVF outcomesGnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSIOvarian reserve assessment for infertility investigation.Female age in ART: when to stop?Maximum basal FSH predicts reproductive outcome better than cycle-specific basal FSH levels: waiting for a "better" month conveys limited retrieval benefitsFertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR.Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.Random anti-Müllerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels : anti-Müllerian hormone in poor responders in assisted reproductive treatmentPrediction of pregnancy in IVF cycles on the fourth day of ovarian stimulation.The practical implications of a raised serum FSH and age on the risk of IVF treatment cancellation due to a poor ovarian response.Serum inhibin B correlates with successful ovulation in infertile women.Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF.Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination.Clinical application of anti-Müllerian hormone as a predictor of controlled ovarian hyperstimulation outcomeAssociation between individual ovarian dimensions with ovarian reserve indices.Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma.Effect of cancer and cancer treatment on human reproduction.
P2860
Q23921319-F75AE75C-1E1F-49CE-81A1-22F85AD3D57FQ24240361-0FC7B37D-F391-4D5D-8726-3F7B2465F5D5Q24596913-EF1757E3-11AD-4C43-ABF2-34238983D671Q24634342-9117EBDF-C1F6-46CB-9635-89C014E3A933Q28067035-229987A0-6F3F-4A6B-8E6E-9356B25E2AF2Q33992236-07FF91FE-17B5-4BD0-A498-67DD561DDB0CQ34018836-4B88E114-F254-4946-8198-B6D754F22CB2Q34037124-4C481D59-6E69-4C17-BEBA-9A41B3062C3EQ34070159-504C4CDF-D9C6-4FC0-BE06-3C44598CA8B7Q34260350-BAC266A8-6136-46C7-8D1B-117844842440Q34268692-52245906-14D1-41FD-A989-B0FDCFB21105Q34415976-3677B7F6-61F6-4207-944D-11355CBE1C2CQ34554644-D3C88CF8-7B10-4946-B8E7-4610D444668AQ34608174-3B79F438-8041-4E85-90A6-B197471D2A0CQ35147438-66C4EB7E-5081-4BEC-80EC-B1539E5027C4Q35156048-93655140-2734-4071-81BE-BEB02C220438Q35166382-73418E3F-8C48-4534-9114-E3223DB85A6EQ35173114-286F46C9-DDCE-4F0F-ADEB-C2858C276F7CQ35492236-D5469E3F-B7F4-41B5-97D7-B4D366838211Q35562391-E49FDAD8-19FE-4DA2-84B6-A3E75EFBDAE9Q35742140-5B5DCF2A-2507-49F7-846F-5335FC23DB7AQ35749173-F5858D38-41B0-4892-BAD4-EC6925900E8AQ35767824-FAEBCA04-CCBA-4240-A7A8-8CC9A677C944Q35767881-C14CE321-ED18-48E9-BBCA-A6BB870045F6Q35825844-421EA993-AF87-43A2-9FD4-5178062ED190Q35884557-9AA40BC8-2976-4BD8-802C-6267C2805DCFQ35953736-14AB41E1-6F22-4C2C-BD51-BC2A1DBB5874Q35966481-153925B8-1052-47F1-8B3F-2BFA71DCA4F4Q36024000-ABE20BFB-3D5A-446B-8A39-A4AD721179EBQ36030666-453D77BA-9F63-4ACC-BA6F-76137C526A62Q36198836-3C3A5183-EFF8-4CA4-BD28-C7A1D577470AQ36268402-976E112C-658C-416B-837E-D877A25259F4Q36269391-BBBC3B1D-50BC-4D09-AC97-0DF05A2F05B5Q36269984-6E3DA00E-44C2-42DD-8B48-67AB6F8C6752Q36270584-8CAEB256-876A-4B11-8434-8CE77A7F66E9Q36418952-6A9E43CF-18EC-4956-87F7-EBAA4E539CDDQ36542516-E19B61C3-16E4-4680-AA30-95E42CC1EAC3Q36651869-714A0517-7AB8-4244-9DA4-6544DF55CD03Q36708416-C0E7A739-C395-42EF-AADD-DF4B7719C578Q36842760-0BA791C3-5D0A-430A-9999-CA73BAA85EFF
P2860
Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Predictors of poor ovarian res ...... al markers of ovarian reserve.
@en
Predictors of poor ovarian res ...... al markers of ovarian reserve.
@nl
type
label
Predictors of poor ovarian res ...... al markers of ovarian reserve.
@en
Predictors of poor ovarian res ...... al markers of ovarian reserve.
@nl
prefLabel
Predictors of poor ovarian res ...... al markers of ovarian reserve.
@en
Predictors of poor ovarian res ...... al markers of ovarian reserve.
@nl
P2093
P1476
Predictors of poor ovarian res ...... al markers of ovarian reserve.
@en
P2093
Egbert R te Velde
Frank H de Jong
Frank J M Broekmans
J Dik F Habbema
László F J M M Bancsi
Marinus J C Eijkemans
P304
P356
10.1016/S0015-0282(01)02983-1
P407
P577
2002-02-01T00:00:00Z